 BOSTON, May 18, 2022 GLOBE NEWSWIRE -- Ikena Oncology, Inc. Nasdaq: IKNA, Ikena, a targeted oncology company forging new territory in patient-directed cancer treatment, today announced that management will be presenting at the H.C. Wainwright Global Investment Conference, taking place May 23-26, 2022, and the Jefferies Global Healthcare Conference, taking place June 8-10, 2022. 